THIAMPHENICOL 500mg Capsule

Category:

COMPOSITIONS :

Thiamphenicol Capsule 500 mg, each capsule contains : Thiamphenicol 500 mg.

 

DESCRIPTIONS : 

Thiamphenicol contain Thiamphenicol as active ingredient is available in dry syrup 125 mg/5 ml and capsule 500 mg.

 

INDICATIONS : 

Thiamphenicol is indicated for infections caused by :

  • Salmonella sp.
  • H. influenzae, especially meningeal infections.
  • Rickettsia.
  • Lymphogranuloma-psittacosis.
  • Gram negative bacteria which cause bacteremia-meningitis.

Not for hepatobilier and gonorrhoeae.

 

DOSAGE AND ADMINISTRATIONS : 

  • Adults, children, infants > 2 weeks : 50 mg/kgBW a day in divided doses, 3 – 4 times daily.
  • Premature infants : 25 mg/kgBW a day in divided doses, 4 times daily.
  • Newborn babies < 2 weeks : 25 mg/kgBW a day in divided doses, 4 times daily.

 

CONTRAINDICATIONS  

  • Patients who known to be hypersensitive to Thiamphenicol or Chloramphenicol.
  • Patients with severe renal or liver impairment.

 

WARNINGS AND PRECAUTIONS

  • Not recommended for infections of unknown cause.
  • Not recommended for mild infections, e.g. cough, flu, influenza, throat infection.
  • Should not be used for prophylaxis of bacterial infections.
  • Blood cell counts must be done before Thiamphenicol therapy.
  • In prolonged treatments and when high doses are needed, it is advisable to perform periodical blood examination.
  • Should not be used for pregnancy and lactating women, because Thiamphenicol may across the placenta and excreted in breast milk.
  • Caution should be taken when given to patients with renal impairment (dose should be reduced).
  • Care should be taken for possibility of superinfection from bacteria and yeasts.
  • Caution should be exercised when prescribing to premature and newborn babies (< 4 weeks).
  • Treatment should be discontinued if reticulocytopenia, leucopenia, thrombocytopenia or anemia occurs.
  • Duration of use should not exceed the specified time limit.

 

DRUG INTERACTIONS :       

  • Phenobarbital reduces therapeutic efficacy of Thiamphenicol.
  • Thiamphenicol may inhibit metabolism of Warfarin, anticonvulsant and Sulphonylurea.
  • Avoid concomitant administration with other drugs which can cause bone marrow depression.
  • Concomitant use with Chloramphenicol may cause cross-resistance.
  • Care should be taken when co-administering with drugs which are metabolized by liver enzymes e.g., Dicumarol, Phenytoin, Tolbutamide, Phenobarbital. 

 

ADVERSE REACTIONS : 

  • Blood dyscrasia e.g., aplastic anemia, hypoplastic anemia, thrombocytopenia and granulocytopenia, particularly irreversible and fatal aplastic anemia.
  • Bone marrow depression with high dose administration and reversible if treatment is discontinued.
  • Hypersensitive reactions, e.g., rash, urticaria, fever, angioedema and anaphylactic reaction (rare).
  • Gastrointestinal disturbances, e.g., nausea, vomiting, glossitis, stomatitis and diarrhoea.
  • Gray syndrome may occur in premature or newborn babies (< 4 weeks).
  • Bacterial and fungal superinfection may occur during prolonged therapy with Thiamphenicol.
  • Other adverse reactions e.g., headache, mental depression and optic neuritis.

 

PRESENTATIONS :

Thiamphenicol Capsule 500 mg Box, 10 strips @ 10 capsules Reg. No. GKL1202345501A1

 

STORAGE :

Thiamphenicol Capsule :

STORE BELOW 30ºC

 

ON MEDICAL PRESCRIPTION ONLY

 

Manufactured by :  

BERNOFARM

Sidoarjo – Indonesia